R&D News
Most Popular R&D Story
Gloom for the pharma industry, yes. Doom? No
AstraZeneca's ($AZN) layoffs announcement yesterday touched off more than its share of hand-wringing. It may be a straw-that-broke-the-camel's-back case; this shedding of 7,300 jobs follows a spate Read more...
Latest Headlines
- February 7, 2012
- February 3, 2012
- December 14, 2011
- December 8, 2011
- December 6, 2011
- August 17, 2011
- February 4, 2010
- February 4, 2010
- November 19, 2009
- April 15, 2009
- February 19, 2009
- January 21, 2009
- October 31, 2008
- October 22, 2008
- October 1, 2008
- October 1, 2008
- September 23, 2008
- April 9, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
